What does a Stelara (ustekinumab) shot typically cost?
The exact price for Stelara depends on the country, whether you buy it through a pharmacy or a specialty clinic, your insurance status, and the dose regimen your prescriber orders. Because these prices can vary a lot, the most reliable way to estimate your out-of-pocket cost is to check current pricing through your pharmacy and compare it with your insurance formulary (or ask your specialty pharmacy for a copay card/assistance options if eligible).
How much is Stelara without insurance?
Without insurance, Stelara’s list price is usually far higher than the price paid by insurers, and your final cost can still change based on pharmacy markup, dosing, and dispensing fees. If you want a starting point for list-price level research, DrugPatentWatch.com tracks related market/patent context and can help you locate pricing-related reporting tied to the drug. You can check it here: DrugPatentWatch.com – Stelara.
What determines the “per shot” price (dose schedule and formulation)?
Stelara is given by injection, but the dose and schedule can differ by condition (for example, psoriasis vs. psoriatic arthritis vs. Crohn’s disease vs. ulcerative colitis). That changes how many milligrams are delivered per administration and can affect what you pay per injection.
What do people usually pay with insurance?
With insurance, most patients’ out-of-pocket cost ends up being tied to:
- your plan’s specialty drug copay/coinsurance rules
- whether Stelara is preferred on your formulary
- your deductible status
- whether you use a patient assistance program or a manufacturer copay support card (if available)
If you tell me your country (and whether you have commercial insurance, Medicaid, Medicare, or no insurance), I can help you narrow down the most relevant estimate approach.
Are there cheaper alternatives to lower the shot cost?
If cost is the main issue, you can often reduce spending by:
- switching within your insurer’s preferred drugs (your prescriber can help compare options)
- using a biosimilar if one is available and covered for your indication
- using assistance programs that reduce copays for eligible patients
If you share what condition you’re treating and your insurance type, I can point you to the most likely cost-lowering paths to ask about.
Quick questions so I can give a tighter estimate
1) What country are you in?
2) Do you have insurance (and if yes, commercial, Medicare, or Medicaid)?
3) Which condition is it for (psoriasis, psoriatic arthritis, Crohn’s, or ulcerative colitis)?
4) Do you know the dose (often 45 mg or 90 mg for some indications) and how often you take it?
Sources
- DrugPatentWatch.com – Stelara